The modern concept of the regulatory role of peptides of the glyproline family in the correction of hemostasis system function during development of diabetes mellitus

Biology Bulletin

Volumn 40, Issue 4, 2013, Pages 386-393

  Lyapina, L A ^a   Myasoedov, N F ^b   Grigor'eva, M E ^a   Shubina, T A ^a   Andreeva, L A ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880116583     PISSN: 10623590     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1062359013040109     Document Type: Article

References (48)

1. Ashmarin, I. P., Karazeeva, E. P., Lyapina, L. A., and Samonina, G. E., The simplest proline-containing peptides PG, GP, PGP, and GPGG: regulatory activity and possible sources of biosynthesis, Biochemistry (Moscow), 1998, vol. 63, no. 2, pp. 119-124.
2. Ashmarin, I. P., Kamenskii, A. A., Lyapina, L. A., et al., Glyprolines as independent regulators and stabilizers of other peptides, Vopr. Biol. Med. Farmatsevt. Khim., 2002, no. 1, pp. 24-27.
3. Ashmarin, I. P., Lyapina, L. A., Andreeva, L. A, et al., Therapeutic effect of glyprolines Pro-Gly and Pro-Gly-Pro in the development of experimental insulin-dependent diabetes, Tromboz Gemostaz Reol., 2008, no. 2, pp. 38-43.
4. Balabolkin, M. I., Klebanova, E. M., and Kreminskaya, V. M., Lechenie sakharnogo diabeta i ego oslozhnenii. Rukovodstvo dlya vrachei (Treatment of Diabetes and Its Complications: A Guide for Doctors), Moscow: Meditsina, 2005.
5. Balabolkin, M. I., Klebanova, E. M., and Kreminskaya, V. M., Differentsial'naya diagnostika i lechenie endokrinnykh zabolevanii (Differential Diagnosis and Treatment of Endocrine Disorders), Moscow: MIA, 2008.
6. Barkagan, Z. S. and Mamot, A. P., Diagnostika i kontroliruemaya terapiya narushenii gemostaza (Diagnosis and Controlled Treatment of Hemostatic Disorders), Moscow: N'yudiamed, 2001.
7. Beller, K. D., Mucodermal use of adapplicator-new pharmaceutical technologies, Biol. Med., 2006, vol. 12, no. 2, pp. 15-18.
8. Berkovskii, A. L., Vasil'ev, S. A., Zherdeva, L. V., et al., Posobie po izucheniyu adgezivno-agregatsionnoi aktivnosti trombotsitov (Study of Adhesion-Aggregation Activity of Platelets: A Guide), Moscow: RAMN NPO Renam, 2003.
9. Brunini, T. M. C., Mendes-Ribeiro, A. C., Ellory, J. C., and Mann, G. E., Platelet-nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular preotection?, Cardiovasc. Res., 2007, vol. 73, no. 2, p. 359-367.
10. Cherkasova, K. A., Lyapina, L. A., and Ashmarin, I. P., Comparative study of modulatory effects of Semax and primary proline-containing peptides on hemostatic reactions, Bull. Exp. Biol. Med., 2001, vol. 132, no. 7, pp. 20-22.
11. Coughlin, S. R., Thrombin signalling and protease-activated receptors, Nature, 2000, vol. 407, p. 258-264.
12. Dedov, I. I., Balabolkin, M. I., and Marova, U. I., Bolezni organov endokrinnoi sistemy (Diseases of the Endocrine System), Moscow: Meditsina, 2000.
13. Dolgov, V. V. and Svirin, P. V., Laboratornaya diagnostika narushenii gemostaza (Laboratory Diagnosis of Hemostasis Disorders), Moscow: Izd. Minzdravsotsrazvitiya RF, 2005.
14. Duttaroy, A., Kanakaraj, P., Osborn, B., et al., Development of a long-acting insulin analog using albumin fusion technology, Diabetes, 2005, vol. 54, pp. 251-258.
15. Gordon, C. W. and Susan, B.-W., A dominant role for glucose in β-cell compensation of insulin resistance, J. Clin. Invest., 2007, no. 117, pp. 81-83.
16. Grigor'eva, M. E., Lyapina, L. A., Shubina, T. A., et al., The protective effects of Pro-Gly-Pro-Arg at elevated blood clotting during experimental hyperglycaemia, Tromboz Gemostaz Reol., 2011, no. 3 (47), pp. 41-46.
17. Hasan, A. A. K., Warnock, M., Nieman, N., et al., Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin, Am. J. Physiol. Heart Circ. Physiol., 2003, vol. 285, no. 1, p. 183-193.
18. Hermanides, J., Cohn, D. M., Devries, J. H., et al., Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study, Thromb. Haemost., 2009, vol. 7, no. 6, pp. 945-949.
19. Jackson, S. P., Nesbitt, W. S., and Kulkarni, S., Signaling events underlying thrombus formation, Thromb. Haemost., 2003, vol. 1, pp. 1602-1612.
20. Kashyap, S., Lara, A., Zhang, R., et al., Insulin reduces plasma arginase activity in type 2 diabetic patients, Diabetes Care, 2008, vol. 31, p. 134-139.
21. Kudrjashov, B. A. and Lyapina, L. A., Non-enzymatic fibrinolysis and its role in the organism, in Thrombosis Thrombolysis, Chazov, E. I. and Smirnov, V. N., Eds., Consultants Bureau, 1986, p. 365.
22. Kudryashov, B. A., Toxic effects of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes, Izv. Akad. Nauk, Ser. Biol., 1993, no. 5, pp. 694-791.
23. Lu, W. M., Lei, S. T., Zhang, Q., et al., Effect of L-arginine on diabetic rats, Nan Fang Yi Ke Da Xue Xue Bao, 2006, vol. 26, no. 10, p. 1434-1445.
24. Lyapina, L. A., Pastorova, V. E., Ul'yanov, A. M., et al., Effect of gelatin and Pro-Gly-Pro peptide on the anticoagulation system state during the development of experimental diabetes mellitus, Vestn. Mosk. Univ., Ser. 16: Biol., 2002, no. 1, pp. 7-10.
25. Lyapina, L. A., Pastorova, V. E., Samonina, G. E., and Ashmarin, I. P., The effect of peptide PGP-rich preparation on haemostatic of rat blood, Blood Coagul. Fibrinol., 2000, vol. 11, no. 5, p. 409-414.
26. Lyapina, L. A., Pastorova, V. E., Obergan, T. Yu., et al., Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, Semax, and Selank and potential for their practical application, Biol. Bull., 2006, vol. 33, no. 2, pp. 153-161.
27. Lyapina, L. A., Andreeva, L. A., Ul'yanov, A. M., et al., Anticoagulant and antidiabetogenic effects of the tripeptide Gly-Pro-Arg during the development of insulin-dependent diabetes Tromboz Gemostaz Reol., 2010a, vol. 46, no. 2, pp. 53-58.
28. Lyapina, L. A., Myasoedov, N. F., Andreeva, L. A., et al., Fibrinolytic and hypoglycemic effects of the Pro-Gly-Pro-Leu peptide during development of insulin-dependent diabetes in rats, Biol. Bull., 2010b, vol. 37, no. 3, pp. 316-320.
29. Lyapina, L. A., Andreeva, L. A., Shubina, T. A., et al., Protective effect of the regulatory peptide Arg-Pro-Gly on the functions of anticoagulation and insular systems of the body in experimental resistant hyperglycemia, Vopr. Biol. Med. Farmatsevt. Khim., 2011, no. 4, pp. 5-9.
30. Macfarlane, S. R., Seatter, M. J., Kanke, T., et al., Proteinase-activated receptors, Pharmacol. Rev., 2001, vol. 53, no. 2, pp. 245-282.
31. McConell, G. K., Effects of L-arginine supplementation on exercise metabolism, Curr. Opin. Clin. Nutr. Metab. Care, 2007, vol. 10, no. 1, pp. 46-51.
32. Mendez, J. D. and Balderas, F. L., Inhibition by L-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes, Biomed. Pharmacother., 2006, vol. 60, no. 1, pp. 26-31.
33. Murav'ev, A. V., Gemoreologiya (eksperimental'nye i klinicheskie aspekty reologii krovi) (Hemorheology (Experimental and Clinical Aspects of Blood Rheology)), Yaroslavl: YaGPU, 2009.
34. Myasoedov, N. F., Andreeva, L. A., Lyapina, L. A., et al., The combined antidiabetogenic and anticoagulation effects of tripeptide Gly-Pro-Arg as estimated in the model of persistent hyperglycemia in rats, Dokl. Biol. Sci., 2011, vol. 438, pp. 135-137.
35. Napoli, C. C., Stanley, W. C., and Ignarro, L. J., Nutrition and cardiovascular disease: putting a pathogenetic framework into focus, Cardiovasc. Res., 2007, vol. 73, no. 2, p. 253-256.
36. Pastorova, V. E., Lyapina, L. A., and Ashmarin, I. P., Prevention of thrombus formation with glyprolines on various models of prethrombotic state and thrombosis in rats, Bull. Exp. Biol. Med., 2003, vol. 138, no. 10, pp. 319-322.
37. Petrik, G. G. and Pavlishchuk, S. A., Metabolism and hemostasis indices in patients with diabetes mellitus type 2 with varying severity of angiopathy, Probl. Endokrinol. (Moscow), 2010, no. 2, pp. 15-19.
38. Piatti, P. M., Monti, L. D., Valcecchi, G., et al., Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients, Diabetes Care, 2001, vol. 24, p. 875-880.
39. Rosental, J., Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle, Am. J. Physiol., 2008, vol. 226, no. 2, p. 411-418.
40. Ruf, W., Dorfleutner, A., and Riewald, M., Specificity of coagulation factor signaling, Thromb. Haemost., 2003, vol. 1, no. 7, pp. 1495-1503.
41. Schmieder, R., Delles, C., Mimran, A., et al., Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes, Diabetes Care, 2007, vol. 30, p. 1351-1356.
42. Shubina, T. A., Myasoedov, N. F., Andreeva, L. A., et al., Anticoagulant, fibrinolytic, and hypoglycemic effects of tetrapeptide Arg-Pro-Gly-Pro, Bull. Exp. Biol. Med., 2012, vol. 153, no. 3, pp. 327-330.
43. Tessari, P., Cecchet, D., Cosma, A., et al., Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients, Diabetes, 2010, vol. 59, p. 2152-2159.
44. Topchii, I. I., The effectiveness of arginine zinc in the prevention of cardiovascular complications in patients with diabetes mellitus and hypertension, Vnutr. Meditsina (Lekaryu-praktiku), 2008, no. 5 (6), pp. 11-12.
45. Ul'yanov, A. M., Lyapina, L. A., Obergan, T. Yu., et al., Antidiabetogenic action of Pro-Gly-Arg and Pro-Gly-Pro-Arg peptides after their intranasal chronic administration to animals, Biol. Bull., 2009, vol. 36, no. 6, pp. 630-634.
46. Vasilijevi, A., Buzadi, B., Kora, A., et al., Beneficial effects of L-arginine-nitric oxide-producing pathway in rats treated with alloxan, J. Physiol., 2007, vol. 584, no. 3, p. 921-933.
47. Yang, W., Chant, V., Kirkpatricki, A., et al., Gly-Pro-Arg confers stability similar to Gly-Pro-Hyp in the collagen triple-helix of host-guest peptides, J. Biol. Chem., 1999, vol. 272, no. 46, pp. 28837-28840.
48. Zakutskii, A. N., Chalisova, N. I., and Subbotina, T. F., Functional arginine-containing amino acid sequences in peptides and proteins, Russ. J. Bioorg. Chem., 2008, vol. 34, no. 2, pp. 149-159.